Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia.
Molecular Oncology
Chorzalska, Anna A; Ahsan, Nagib N; Rao, R Shyama Prasad RSP; Roder, Karim K; Yu, Xiaoqing X; Morgan, John J; Tepper, Alexander A; Hines, Steven S; Zhang, Peng P; Treaba, Diana O DO; Zhao, Ting C TC; Olszewski, Adam J AJ; Reagan, John L JL; Liang, Olin O; Gruppuso, Philip A PA; Dubielecka, Patrycja M PM